Insider Transactions in Q3 2024 at Bausch Health Companies Inc. (BHC)
Insider Transaction List (Q3 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 30
2024
|
John Paulson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,659
+2.86%
|
$61,272
$8.16 P/Share
|
|
Sep 30
2024
|
Brett Icahn Director |
BUY
Grant, award, or other acquisition
|
Direct |
4,059
+2.59%
|
$32,472
$8.16 P/Share
|
|
Sep 30
2024
|
Amy B Wechsler Director |
BUY
Grant, award, or other acquisition
|
Direct |
842
+0.4%
|
$6,736
$8.16 P/Share
|
|
Sep 06
2024
|
Seana Carson EVP, General Counsel |
SELL
Open market or private sale
|
Direct |
13,370
-2.98%
|
$80,220
$6.21 P/Share
|
|
Sep 05
2024
|
Seana Carson EVP, General Counsel |
SELL
Payment of exercise price or tax liability
|
Direct |
51,337
-10.27%
|
$308,022
$6.19 P/Share
|
|
Sep 05
2024
|
John S Barresi SVP, Controller & CAO |
SELL
Payment of exercise price or tax liability
|
Direct |
3,982
-2.58%
|
$23,892
$6.19 P/Share
|
|
Aug 30
2024
|
Thomas Appio Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
14,683
-1.07%
|
$73,415
$5.93 P/Share
|
|
Aug 19
2024
|
Jean Jacques Charhon EVP, CFO |
BUY
Grant, award, or other acquisition
|
Direct |
298,838
+50.0%
|
-
|
|
Jul 18
2024
|
John S Barresi SVP, Controller & CAO |
BUY
Grant, award, or other acquisition
|
Direct |
49,254
+24.19%
|
-
|
|
Jul 15
2024
|
Aimee J. Lenar EVP, US Pharma |
BUY
Grant, award, or other acquisition
|
Direct |
144,352
+50.0%
|
-
|